Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 360 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pharmacist intervention Clear all

Conditions: Heart Failure With Preserved Ejection Fraction
Interventions: HF Kit and Follow-ups; Behavioral
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 18 Years to 90 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Brick, New Jersey

Conditions: Infectious Disease, Pneumonia, Bacterial, Influenza, Zoster; Herpes
Interventions: Pharmacist-led Intervention (PHARM), Peer-led Intervention (PEER); Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 50 Years and older
Enrollment: 335 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Peripheral Artery Disease
Interventions: Intervention A - Vascular Care + site 6MWT administration, Intervention B - Standard Care + site 6MWT administration, Intervention A - Vascular Care + CPC EQuIP 6MWT administration, Intervention B - Standard Care + CPC EQuIP 6MWT administration; Other
Lead sponsor: Colorado Prevention Center; Other
Eligibility: Not listed
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hypertension
Interventions: Feasibility Interview, Team Based Equity Conscious Telemedicine Hypertension Intervention, Usual Care; Other · Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Low-Value Care
Interventions: EVOLV-Rx dashboard; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 65 Years and older
Enrollment: 1,161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania • Wilkes-Barre, Pennsylvania

Conditions: Diabetes Mellitus, Type 2
Interventions: Continuous Glucose Monitor, Usual Care; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Hiv
Interventions: Collaborative drug therapy management model, Cabotegravir/Rilpivirine; Behavioral · Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Venous Thromboembolism, Patient-Centered Care
Interventions: Enhanced Assessment and Education; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 162 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Hypertension, High Blood Pressure
Interventions: LINKED-BP Program; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 472 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 20
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Bowie, Maryland + 11 more

Conditions: Opioid-use Disorder, Opioid Dependence, Opioid Use
Interventions: Discharge Order Sets, Pharmacist-Led Discharge Counseling and Communication, Post-discharge Pain Management Follow-up, Patient Engagement Pain Management App; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Heart Failure
Interventions: SGLT2i, beta blocker, ARNI, MRA, MTD, Education-First; Drug · Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 503 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Severe Hypertension, Hypertension
Interventions: Emergency Department-Initiated Team-Based Care, Usual Care; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 85 Years
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 5
States / cities: Brownstown, Michigan • Dearborn, Michigan • Detroit, Michigan + 1 more

Conditions: Opioid Overdose Prevention, HIV Prevention and Care, Harm Reduction
Interventions: PROTECT-ED Care Coordination; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cardiovascular Diseases, Diabetes Mellitus, Medication Adherence
Interventions: Pharmacist-led, technology enabled education intervention; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Breast Cancer, Lung Cancer, GI Cancer
Interventions: Pharmacy Intervention, Usual Care; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 65 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV, Inhaled Corticosteroid, Proton Pump Inhibitor, Smoking Cessation, Pneumonia
Interventions: E-consult; Other
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 18 Years and older
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Boise, Idaho • Minneapolis, Minnesota • Seattle, Washington

Conditions: Hypertension
Interventions: Hypertension Management Model; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 35 Years to 79 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Nash, Tennessee • Nashville, Tennessee

Conditions: Diabetes
Interventions: Proactive population care (active application of HOAP principles in patients flagged as high risk for hypoglycemia), Usual care, after system-side dissemination of HOAP; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Pleasanton, California

Conditions: Diabetes Mellitus, Hypertension, Coronary Artery Disease, Atrial Fibrillation, Stroke
Interventions: PHCVRS Intervention, Personal Health Record; Other
Lead sponsor: Korey Kennelty; Other
Eligibility: 50 Years and older
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 12
States / cities: Akron, Iowa • Belmond, Iowa • Cedar Rapids, Iowa + 9 more

Conditions: Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation, Drug Metabolism, Poor, CYP2D6-RELATED, Drug Metabolism, Poor, CYP2C19-RELATED, Cytochrome P450 Enzyme Deficiency, Cytochrome P450 CYP2D6 Enzyme Deficiency, Cytochrome P450 CYP2C9 Enzyme Deficiency, Cytochrome P450 CYP2C19 Enzyme Deficiency, Cytochrome P450 CYP3A Enzyme Deficiency, Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant, Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Interventions: Pharmacogenetic testing; Genetic
Lead sponsor: Genelex Corporation; Industry
Eligibility: 50 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Searcy, Arkansas

Conditions: Anticoagulants, Atrial Fibrillation, Venous Thromboembolism
Interventions: Multifaceted behavioral intervention; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years and older
Enrollment: 1,260,576 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Bedford, Massachusetts

Conditions: Pharmacogenomics, Old Age
Interventions: Behavioral Intervention, Diagnostic Test, Data Analysis; Behavioral · Diagnostic Test · Other
Lead sponsor: Tabula Rasa HealthCare; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Smoking Cessation, Smoking, Cigarette, Smoking Reduction, Smoking, Smoking, Tobacco, Quitting Smoking
Interventions: 4 weeks of Nicotine lozenge, 8 weeks of Nicotine Replacement Therapy Patch, QuitAid, Smokefree TXT, Tobacco Quitline, 4 weeks of Nicotine Replacement Therapy Patch, 8 Weeks Nicotine Lozenge; Drug · Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 768 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Tobacco Cessation, Tobacco Abstinence, Tobacco Use, Tobacco Use Cessation, Tobacco Dependence
Interventions: Nicotine Replacement Therapy (NRT), Wellness Coaching; Drug · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Transitions of Care Clinic (TOCC)

Vaccination Education Through Pharmacists and Senior Centers (VEPSC)

Implementation of Vascular Care Team to Improve Medical Management of PAD Patients

Team Based Equity Conscious Telemedicine Approach to Hypertension

EVOLV-Rx VA: Evaluating Opportunities to Decrease Low-Value Prescribing in Community Living Centers

Addressing Disparities in Diabetes Care

Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs

Anticoagulation Medical Home

Home Blood Pressure Telemonitoring LINKED With Community Health Workers to Improve Blood Pressure

Prevention of Opioid Use Disorder After Surgery

COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure

Emergency Department-Initiated Team-Based Care for Severe Hypertension

Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department

Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients

Pilot Study of a Pharmacy Intervention for Older Adults With Cancer

Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults

Nashville - Hypertension Management Model

Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients

Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care

Pharmacogenetic Testing Among Home Health Patients

Improving Anticoagulation Control in VISN 1

Pharmacist-led Interventions to Improve Medication Use

Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia

Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness